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Abstract 
Gold nanoclusters (Au NCs) are an emerging type of theranostic agents combining therapeutic and 
imaging features with reduced toxicity. Au NCs stabilized by a zwitterion ligand with a fine control 
of the metal core size and the ligand coverage were synthesized by wet chemistry. Intense 
fluorescence signal is reported for the highest ligand coverage whereas photoacoustic signal is 
stronger for the largest metal core. The best Au NCs candidate with an average molecular weight of 
17 kDa could be detected with high sensitivity on a 2D- NIR imaging instrument (LOD = 2.3 µM) 
and by photoacoustic imaging. In vitro and in vivo experiments demonstrate an efficient cell uptake 
in U87 cell lines, a fast renal clearance (t1/2α= 6.5±1.3 min) and a good correlation between near 
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infrared fluorescence and photoacoustic measurements to follow the early uptake of Au NCs in 
liver.   
 
Introduction 
The sub-class of nanoclusters (NCs) in the wide library of metal nanoparticles have found a 
growing interest over the last few years for in vivo studies notably for cancer applications. Those 
metal NCs, mainly gold, are made of ten to hundred atoms and usually presented as species filling 
the gap between molecules and nanoparticles1-4. Au NCs present several features making them 
appealing for cancer therapy thanks to i) their high renal clearance5, 6 reducing toxicity risk, ii) the 
relatively high tumor retention by passive uptake7, 8, iii) the ability to trigger cell death under light 
illumination9 or radiosensitization10-12, and iv) the detection by multimodal imaging techniques13-15.   
In optical imaging, one of the great advantages of Au NCs compared to plasmonic Au NPs is 
related to the ability to visualize them by fluorescence in the red-NIR region (650-800 nm), a 
spectral window suitable for in vivo studies due to the reduced tissue scattering and low blood 
absorption16, 17. In addition, the high electronic number of gold (Z=79) allows a detection of gold 
particles by computed X-ray tomography (CT)5 and by  photoacoustic imaging (PAI) 18, 19. With the 
development of new contrast agents such as gold nanorods and nanocages, PAI combines the most 
compelling features of optical imaging and ultrasound imaging, providing both high optical contrast 
and high ultrasounds resolution including in vivo in deep tissues20-­‐22.	  	  
Au NCs stabilized by glutathione (GSH) are probably one of the most described NCs in the 
literature with a precise control of their size and their structure23-26. The natural peptide GSH has a 
zwitterionic structure and, when coated on particle surface, could prevent the detection by 
macrophages27. Recently, we investigated the optical properties and the behavior in cell 
environment of Au NCs stabilized by bidentate thiol zwitterionic ligand (Zw) which are highly 
stable Au NCs with intense fluorescence tunable in the near-infrared region28-30.  
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In this study, we aimed to determine the influence of the core size and the ligand coverage of gold 
particle to their fluorescence and their photoacoustic signals. For this purpose, gold particle of 
different size from the small plasmonic NPs (i.e size ∼ 4 nm) to NCs (i.e size <2.5 nm) stabilized by 
a zwitterion ligand were prepared. Then, we investigated the behavior of the best candidate 
exhibiting both high fluorescence and photoacoustic signals in cells and in mice. Additional 
information are also reported on the NC size determined by mass spectrometry for Au NCs 
stabilized by zwitterionic ligand. 
 
Materials and Methods 
All products were purchased from Sigma Aldrich and MilliQ (Millipore, France) water was used for 
all experiments. 
1- Particle synthesis. 
Thioctic-zwitterion (Zw, C15H30N2O4S3, M~399 g.mol-1) was synthesized following the protocol 
described elsewhere28. Au NCs with zwitterion (AuZw), were prepared by the addition of gold salt 
(HAuCl4.3H2O, 50 mM) to a basic solution (pH 10) containing the ligand in the presence of the 
strong reducing agent NaBH4 (50mM) and stirred for 15 hours. Zwitterion stabilized Au NCs were 
synthesized with the molar ratio Au:Zw:NaBH4 = 1:1:2, 1:2:2, and 1:5:2 molar ratio. Zwitterion 
stabilized Au NPs were synthesized with the molar ratio Au:Zw:NaBH4 = 2:1:2, and 5:1:2. 
Afterwards, solutions were filtered twice with Amicon 3 kDa cut-off filters at 13,600 rpm for 20 
min to remove excess free ligands, adjusted to pH 7, concentrated to 5 mg gold/mL in water and 
kept refrigerated until use. 
Protected Au25GSH18 clusters were synthesized in two steps as described by T. Pradeep and co-
workers31 . Briefly in a first step, the complex formed between HAuCl4 and glutathione GSH 
(Au:GSH= 1:4) was reduced in a methanolic solution (0°C) with NaBH4. The resulting 
precipitate(Au@SG) was washed with methanol and dried. In a second step, Au@SG was dissolved 
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in water with 1mM of GSH and heated at 55°C for 12h. Solution was centrifuged and Au25GSH18 is 
precipitated from the supernatant by adding methanol. The precipitate was washed several time with 
methanol before drying in vacuum. 
 
2- Instruments & techniques. 
Transmission electron microscopy (TEM) images of the NCs and NPs were measured on a FEI 
Tecnai G2 Twin TEM. XPS investigation was performed in a K-Alpha+ spectrometer 
(ThermoFisher Scientific) using a microfocused, monochromated Al Kα X-ray source (400 µm spot 
size). The spectra were fitted with one or more Voigt profiles (BE uncertainty: ±0.2 eV) and 
Scofield sensitivity factors were applied for quantification32. All spectra were referenced to the C1s 
peak at 285.0 eV binding energy (C–C, C–H) and controlled by means of the well-known 
photoelectron peaks of Cu, Ag, and Au, respectively. Measurements were performed on two 
different locations of dried samples. Evolution of the Au NC size as a function of the ratio metal–
ligand was determined by electrospray ionization (ESI) on a commercial quadrupole time-of-flight 
(micro-qTOF, Bruker-Daltonics, Bremen, Germany, mass resolution ∼10,000). The samples were 
prepared by diluting mother solution in water, to a final concentration of 0.25-0.5 mg.mL−1 in 
50/50% water/meOH v/v. The samples were analyzed in positive ion mode: each data point was the 
summation of spectra over 5 min. External calibration was carried out with a set of synthetic 
peptides.  
Absorbance measurements on diluted samples were performed on a Evolution 201 
(Thermoscientific) UV-vis spectrophotometer between 300 and 1000 nm. Fluorescence spectra 
were recorded on a Perkin Elmer LS45 Fluorescence Spectrometer. Fluorescence imaging was 
performed with a NIR 2D-Fluorescence Reflectance Imaging device (Fluobeam 800®, Fluoptics, 
France). The excitation is provided by a class 1 expanded laser source at 780 nm and the irradiance 
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on the imaging field is 100 mW/cm2. The fluorescence signal is collected by a CCD through a High 
pass filter with a high transmittance for wavelength > 830 nm. 
PAI was performed on The VevoLAZR system (Visualsonics, Fujifilm) using the LZ201 transducer 
(256 elements linear array; 9-18 MHz) allowing a 44 µm axial resolution. The laser is tunable 
between 680 and 970 nm and acquisitions can be made continuously with 1 nm steps providing a 
photoacoustic spectrum. 
 
3- Cell experiments 
U87MG cells were cultured in six-well plates one day before the experiment. The Au NCs were 
added to the cell medium at 50 µg gold/mL (eq. 35 µM) for the indicated time (4 hours to 24 hours), 
and the cells were incubated at 37°C or 4°C. Then, the cells were resuspended with trypsin and 
carefully washed in PBS before analysis. Propidium Iodide was added to the cell suspension 
according to the manufacturer’s instructions (BD Pharmingen, Belgium). The cells were analyzed 
using LSR II (Becton Dickinson, France). The 405 nm laser was used to excite the Au NCs, and the 
signal was collected after a long-pass 750 nm, at 780/60 nm. Propidium iodide was excited at 488 
nm, filtered with the long-pass 655 nm, and its emission was collected at 660/20 nm. Specific 
compensations were applied to prevent the overlapping of the signals. 
 
4- In vivo experiments  
Six weeks old NMRI nude mice (Janvier, France) were anesthetized (air/isoflurane 4% for 
induction and 1.5% thereafter) and were injected intravenously via the tail vein with 200 µL of Au 
NCs at 600 µM. In vivo fluorescence imaging was performed before and 1, 3, 5 and 24 hours after 
injection. Mice were euthanized at 1, 5 or 24 hours post injection (n = 3 mice per time point) and 
organs were harvested for ex vivo fluorescence imaging. 
Three other mice were injected and blood samples were collected 10 sec and 5, 10, 15, 20, 30, 45 
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and 60 min after injection and were centrifuged (10 min at 2000 g) to separate plasma. Fluorescence 
imaging was then performed on plasma samples. 
For PAI, an US gel (Parker Laboratories Inc., USA) was applied on the mouse body, the transducer 
was placed above the liver and a 30x30 mm2 slice was imaged both in Bmode (ultrasound) and in 
PA mode at 710 nm before and 1, 5 and 24 hours after intravenous injection.  
 
Results and Discussion 
1- Characterization of Au NCs 
We choose the ligand Zw (figure 1a) to produce gold particle of different size because this molecule 
was shown to strongly improve the colloidal stability of particle33 and also to obtain Au NCs 
exhibiting one the highest fluorescence intensity reported so far28, 30, 34. Molar ratio Au:Ligand has 
been modified during the synthesis in order to play both on the final metal core size and on the 
ligand coverage. Thus, a molar ratio Au> Ligand leads to NP for Au:Zw = 2:1 and 5:1 and a molar 
ratio Au≤ Ligand leads to NCs for AuZw = 1:1, 1:2, and 1:5. TEM images (figure S1) show clearly 
a decrease of the metal core diameter when the amount of the ligand increases from 4.8±1.2 nm for 
AuZw 5:1 to less than 2.5 nm for AuZw 1:2 and AuZw 1:5. In the case of Au NCs (i.e for AuZw 
1:1, AuZw 1:2 and AuZw 1:5), mass spectrometry is reckoned as suited technique to determine the 
full size and the structure of metal NCs35-40. We previously attempted to determine specific magic 
clusters using MALDI-Tof technique on those types of NCs without any success28. Here, the high 
mass setting is optimized for the AuZw NCs. AuZw NCs contain multiple groups capable of being 
ionized and the ESI source can produce highly charged ions. For those molecules that can sustain 
multiple charges, a distribution of charge states is often observed in the mass-to-charge spectrum. 
This multiplicity of states gives rise to an “envelope” of peaks in the spectrum. The distribution of 
charges is observed in the m/z range 1000 - 8000 after electrospraying in positive mode water 
solution containing the nanoparticles (figure S2). Although the position of the peaks in the mass 
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spectra is stable, the relative abundance of the different peaks is found to be slightly dependent on 
the ESI-MS conditions. A multiplicative correlation algorithm (MCA) is used to estimate the mass 
of nanoparticles from the mass-to-charge spectra produced by electrospray ionization mass 
spectrometry41. The multiplicative correlation is designed to enhance the deconvoluted signal when 
the parent molecule is distributed into several charge states in the spectrum measured. This 
approach is summarized by the following formula42: 
 
where  is the intensity calculated in the spectrum for mass m,   is the intensity in the 
mass-to charge spectrum, grms is the root-mean-square (rms) value of the signal measured. 
As the Au NCs contain multiple ionized groups (Zw ligands), a distribution of charge states is 
observed in the mass-to-charge spectrum, and the MCA is used to estimate the mass of the Au NCs 
from the mass-to-charge spectra produced by the ESI-MS. As seen in figure 1b, for AuZw 1:1, the 
distribution is centered at 11000 Da with a second distribution (with a smaller intensity) at ~13500 
Da. For AuZw 1:2, the mass increased to 17200 Da (with a second distribution with a smaller 
intensity at ~13600 Da). For AuZw 1:5, the mass reached to 32850 Da (with a second distribution at 
~30660 Da and a third at ~28600 Da). Therefore, an obvious increase of the molecular weight of Au 
NCs occurs when the ligand content increases as previously reported28. However in this study, we 
obtain a higher resolution in terms of size distribution thanks to the presence of an “envelope” of 
peaks in the spectrum and the multiplicative correlation algorithm designed to enhance the 
deconvoluted signal originated from the NCs. XPS experiments provide information about the 
atomic concentration of each element and the nature of interaction within the sample. Contribution 
of gold from the core bound directly to Zw via thiol groups and compared to the total amount of the 
ligand could be followed by looking at the energy binding of S 2p, in particular the component at 
161,8 eV characteristic for S-Au (figure S3). In figure 1c, the ratio of gold concentration to the total 
rms
z
zz
gzmgmf /)()(
1
0
∏
=
=
)(mf )( zmg
	   8	  
concentration of sulphur (Au/Stotal) or to the concentration of sulphur bound to gold, hydrogen and 
to carbon (Au/(S-Au+S-C+S-H)) indicates a constant decrease when Zw increases. This behavior 
confirms that Zw continue to bind Au core even at the molar ratio Au:Zw= 1:5. AunZwm 
stoichiometry is then evaluated based on the average mass estimated with deconvoluted ESI mass 
spectra and XPS results (giving access to Au/S ratio). Results show m>n by a factor m/n higher 
than 2 for AuZw 1:1, AuZw 1:2, and AuZw 1:5, which is different for instance from the one 
reported for thiolated-protected clusters using glutathione4. Thus, the formation of AuZw could be 
seen rather like an organic charged layer coated onto ultra-small gold particles. Despite repetitive 
purification steps, the high reactivity of the bidentate thiotic group of Zw with gold and the strong 
electrostatic interaction inter-ligand due to the presence of the sulfonate and ammonium in Zw 
might prevent then the identification of magic size ”superatom”.  
Absorbance measurements of AuZw sols show the standard plasmonic band at λ= 520 nm for 
AuZw 5:1 and AuZw 2:1 and usually observed for Au NPs with size above 3 nm1. Increase of 
ligand content during the synthesis leads to the fall of the plasmonic band with a decrease of the UV 
band absorption (figure S4). We can see an isobectic point at λ= 420 nm between AuZw 1:2 and 
AuZw 1:5 that could be attributed to the absorption of the ligand Zw in the UV-visible region28. 
Fluorescence (figure S5) is strongly enhanced when Zw>Au with a rise at λ= 820 nm followed up 
by a blue-shift to λ= 750 nm like it was previously reported28. Plasmonic NPs exhibit very weak or 
no fluorescence43. However, AuZw 2:1 sample still presents some fluorescence signal despite the 
presence of a plasmon band. This effect could be related either to the presence of smaller NCs 
observed in HRTEM that cannot be separated to the NPs in the solution due to the low variation in 
weight or to the weak quenching effect of plasmonic NP due to the small particle size. 
 
2- Phantom experiments 
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Fluorescence intensity of the aqueous AuZw sols (2 mg gold/mL) prepared at different molar ratio 
Au:Zw was measured on a NIR 2D-Fluorescence Reflectance Imaging device (λexc. 780 nm; LP 830 
nm). This medical device is dedicated to non-invasive or intraoperative in vivo imaging and has 
been used to guide surgical procedures44, 45. Phantom imaging illustrated in figure 2a shows an 
exponential enhancement of the fluorescence intensity when increasing Zw content with the highest 
signal for AuZw 1:5, which is in agreement with the fluorescence measurements obtained on the 
spectrofluorimeter. The same trend is observed with a series of dilution up to 100 µg gold/mL from 
the concentrated AuZw sols to insure no self-absorption in this concentration window. 
Photoacoustic signal of the different AuZw sols exhibit a similar profile (figure 2b) with a constant 
decrease of the intensity at longer wavelength from 680 nm to 910 nm followed by a slight 
augmentation until λ= 930 nm and then decreases again. In figure 2c, photoacoustic signal of AuZw 
is plotted fixing the wavelength at λ= 710 nm and drops drastically when Zw content increased 
especially between AuZw 2:1 and AuZw 1:1. Evolution of normalized fluorescence and 
photoacoustic signals is illustrated in figure 2d and shows an opposite trends with a stronger 
fluorescent signal for AuZw 1:5 whereas AuZw 5:1 exhibit the highest photoacoustic signal. This 
observation could be logically explained by the fact that high ligand coverage surrounding the metal 
core of the NCs improves the rigidity of the network leading to a strong fluorescence intensity46. 
Inversely, particle with a bigger metal core like for AuZw 2:1 and AuZw 5:1 with size> 4 nm will 
produce heat under illumination leading to more intense vibration and then stronger photoacoustic 
signal. 
We then decided to select the sample AuZw 1:2 as the optimal candidate for in vitro and in vivo 
experiments because it exhibits both quite intense fluorescence and enough signal to be detected by 
PAI. Knowing the molecular weight of AuZw 1:2 ∼17kDa, and the weight concentration of gold per 
sample (∼50%), AuZw concentration could be then expressed in M (mol/L) in this study. 
Fluorescence calibration of AuZw 1:2 between 4.5 µM to 600 µM suggests a limit of detection to 
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2.3 µM by fixing a signal/noise= 2 using PBS solution as control (figure 3a). This sensitivity can be 
considered as relatively high taking account of the low absorption of Au NCs at this excitation 
wavelength (see absorbance and fluorescence emission figures S4, S5). Photoacoustic calibration in 
figure 3b indicates a linear behaviour between 70 to 600 µM with signal>0.2 at 140 µM. 
 
3- In vitro experiments 
In vitro cell studies have been performed on glioblastoma cells in culture (U87MG) incubating 
those cells with AuZw 1:2 at 35 µM in complete medium during 4, 8, or 24 hours. Flow cytometry 
analysis illustrated in figure 4a indicates an enhancement of the fluorescent signal in cells originated 
from the Au NCs overtime (quantification reported in figure 4c) reaching more than 90% after 24 
hours of incubation. Experiment performed at 4°C shows a very weak Au NC uptake in cells after 4 
hours of incubation with less than 5% positive cells compared to the same experiment set at 37°C 
with 20.96% positive cells. This result confirms the low passive diffusion of those particles 
suggesting that AuZw 1:2 probably accumulates on the cell surface before an uptake by active 
process29, 30, 47.  Cytotoxicity assays have been performed using propidium iodide (figures 4b, 4c) 
and show no significant toxicity (<3%) until 24 hours incubation and even using Au NC 
concentration up to 100 µM (data no shown).  
  
4- In vivo experiments 
Blood pharmacokinetic of AuZw 1:2 (M∼17 kDa; 600 µM in PBS) was measured by fluorescence 
imaging and shows a rapid clearance with an estimated half-life t1/2α= 6.5±1.3 min from a one 
compartment modelization. Wash out from blood is even faster using the well-characterized 
Au25GSH18 (M∼11kDa)31 in the same condition with t1/2α= 1.2±0.2 min. Those estimated half-life 
values are in the same order than previous in vivo studies using Au NCs stabilized by the tripeptide 
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glutathione (GSH) reported by Zheng’s team with t1/2α= 5.4±1.2 min with a NC size of 40 kDa
8 and 
by Chen et al. with t1/2α= 0.7±0.1 min
6. This indicates first that reducing particle’s size drastically 
shortens the blood circulation and suggests also that the zwitterionic ligand Zw coated on Au NCs 
leads to a longer blood circulation than GSH looking at the entire particle size. Non-invasive in vivo 
fluorescence imaging confirms the high renal clearance with the strong accumulation of AuZw 1:2 
in the bladder 1 hour after intravenous injection (figure 5b) in the same way that it was observed for 
others Au NCs6, 7. 
We evaluated the biodistribution of AuZw 1:2 in liver by using fluorescence imaging (figures 6 a, c, 
e) and PAI (figures 6 b, d, e) 1, 3, 5, and 24 hours after intravenous injection. We found a good 
agreement between these two imaging techniques indicating an early accumulation of the Au NCs 
in the liver between 1 and 3 hours followed by a slow elimination until 24 hours. Mice were 
sacrificed at 1, 5, and 24 hours and biodistribution analysis from ex vivo fluorescence imaging 
illustrated in figure 6e shows the early elimination by kidney and bladder at 1 hour post injection 
which confirms the efficiency of kidney filtration for those Au NCs. The ex vivo data also indicate a 
weak fluorescence signal from all the other organs with the exception of the liver presenting an 
early uptake of Au NCs.  
 
Conclusion 
Herein, we demonstrate the ability to track gold nanoclusters (Au NCs) in vivo by two different 
imaging techniques based on 2D-NIR fluorescence and photoacoustic signal. Au NCs stabilized by 
a zwitterionic ligand could be synthesized by finely tuning metal core size/ligand coverage in order 
to provide the best compromise fluorescence/photoacoustic signals. Those Au NCs displayed high 
renal clearance and both imaging techniques indicate an early Au NC uptake in liver. Therefore, the 
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low toxicity and the detection of Au NCs by fluorescence imaging in the NIR region and by 
photoacoustic imaging make those contrast agents highly promising for future in vivo studies.    
 
Supplementary materials: see the supporting information for the physico-chemical (TEM, 
XPS, ESI-MS) and optical (absorbance, fluorescence) properties of Au NCs. 
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Figure 1. (a) Chemical formula of the thioctic bidentate zwitterionic ligand Zw. (b) Deconvoluted 
ESI MS spectra of AuZw 1:1, AuZw 1:2, and AuZw 1:5. (c) Concentration of gold (atomic%) with 
respect to total concentration sulphur (Stotal) or to sulphur bind to gold, carbon and thiol (S-Au+S-
C+S-H) from Zw extracted from XPS measurements. 
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Figure 2. (a) Fluorescence intensity of AuZw sols (2 mg gold/mL) measured with a NIR 2D-
Fluorescence Reflectance Imaging device (λexc. 780 nm; LP 830 nm). Photoacoustic signal of AuZw 
sols (2 mg gold/mL) (b) between 690 and 970 nm and (c) at λexc. 710 nm. (d) Normalized 
fluorescence and photoacoustic signals for AuZw (2 mg gold/mL). 
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Figure 3. (a) Calibration of AuZw 1:2 fluorescence intensity between 4.5 to 600 µM in water 
measured with a NIR 2D-Fluorescence Reflectance Imaging device (λexc. 780 nm; LP 830 nm). (b) 
Calibration of AuZw 1:2 photoacoustic signal between 70 and 600 µM in water. 
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Figure 4. (a, c) Flow cytometry results and (b, c) toxicity tests by propidium iodide on U87MG cells 
incubated with AuZw 1:2 (35 µM in complete medium) at different time points and at 37°C and at 
4°C for 4 hours.  
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Figure 5. (a) Blood pharmacokinetic of AuZw 1:2 and Au25GSH18 after intravenous injection (200 
µL; 600 µM). Au NC concentration is determined from the fluorescence intensity values. (b) Non-
invasive in vivo 2D fluorescence imaging 1 hour after intravenous injection of AuZw 1:2 (600 µM, 
V= 200 µL) illustrating the strong elimination of Au NC by the bladder. 
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Figure 6. Kinetic of AuZw 1:2 uptake in liver by (a) fluorescence and (b) photoacoustic imaging. 
(c) Non-invasive in vivo fluorescence (left) and  (d) photoacoustic (right) imaging 3 hours after 
AuZw 1:2 intravenous injection (200 µL; 600 µM). (e) Biodistribution analysis from ex vivo 
fluorescence imaging in different organs 1 hour, 5 hours, and 24 hours after Au NC intravenous 
injection (200 µL; 600 µM).   
